Company
Mediclinic International plc
Headquarters: Stellenbosch, South Africa
Founded: October 3, 1983
Employees: 30,470
CEO: Dr. Carel Aron van der Merwe D.A. (SA), F.C.A. (SA), M.B.Ch.B.
Market Cap
R88.13 Billion
ZAR as of May 1, 2023
US$4.68 Billion
Mediclinic International plc Categories
South Africa Healthcare Medical Care FacilitiesSouth Africa Healthcare South Africa Medical Care Facilities
Top Competitors by Market Capitalization
Industry: Medical Care Facilities
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 18 day case clinics, 18 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 454 theatres with approximately 11,?449 inpatient beds in Switzerland, South Africa, Namibia, and the United Arab Emirates. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Mediclinic International plc has the following listings and related stock indices.
Stock: JSE: MEI wb_incandescent
Stock: LSE: MDC wb_incandescent
Stock: FSX: MO4 wb_incandescent
Key People
Dr Edwin Hertzog (Chairman) Dr Ronnie van der Merwe (CEO)
Financials
Revenue: £2,995 million (2021)
Operating income: £209 million (2021)
Net income: £79 million (2021)